- Name: Solomon Zeleke, Ph.D.
- Institution: Idaho State University
- Department: Biomedical and Pharmaceutical Sciences
- Phone: 208-380-3779
- Email: email@example.com
Summary: My medicinal chemistry research program investigates the discovery and development of small-molecule inhibitors targeting cyclin-dependent kinases (CDKs). I have identified novel clinical stage CDK4-, CDK4/6-, and CDK12-selective inhibitors as candidate therapeutics for cancer. I am interested in the design and synthesis of CDK-selective inhibitors, and my current efforts are focused on discovering novel CDK-selective inhibitors and degraders.